APLS
Apellis Pharmaceuticals Inc
NASDAQ · Biotechnology
$23.49
+0.93 (+4.12%)
Performance
1D
—
1W
+2.89%
1M
+1.25%
3M
+20.40%
6M
-11.63%
1Y
-18.10%
YTD
-9.16%
Open$22.68
Previous Close$22.56
Day High$23.58
Day Low$22.57
52W High$30.53
52W Low$16.10
Volume1.83M
Avg Volume4.39M
Market Cap2.97B
P/E Ratio66.07
EPS$0.30
SectorBiotechnology
Volume Analysis
0.42x average volume
Technical Indicators
SMA 50
$23.37
Above
SMA 200
$22.10
Above
RSI (14)
75.7
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
28 analysts
Price Target
-4.0% upside
Current
$23.49
$23.49
Target
$22.54
$22.54
$12.93
$22.54 avg
$29.12
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 797.89M | 3.03B | 2.81B |
| Net Income | -202,060,754 | 93.04M | 81.85M |
| Profit Margin | -25.3% | 3.1% | 2.9% |
| EBITDA | -170,834,333 | 115.17M | 115.66M |
| Free Cash Flow | — | 42.87M | 48.47M |
| Rev Growth | +127.2% | +21.3% | +20.6% |
| Debt/Equity | 1.98 | 0.57 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |